Reorg, New CEO
etrials: Technology Will Be Key
A conversation with Denis Connaghan of etrials, who recently became the new CEO of etrials.
Late last month, in sun-blasted Phoenix, the 2011 Partnerships In Clinical Trials conference featured Denise Calaprice-Whitty of The Avoca Group. We had interviewed Calaprice-Whitty last year, for this article, and had privately hoped to coast through her presentation. But that proved impossible, as she had new data. We paid close attention. Her employer is specializing in mapping the twists and turns of the outsourcing age—both the disappointments for those who are moving work outside their companies, and the frustrations of those taking on such labors. The news in Phoenix was neither bleak nor rosy. The Avoca Group's surveys and consulting engagements suggest that happiness is unevenly distributed throughout the contract research landscape. Some sponsors are extremely pleased and believe outsourcing is working well. At other firms, less enthralled with outsourcing, quality is a concern. “Quality is on the dragging down end of what is contributing to sponsor dissatisfaction with their providers,”…more...
Organizing a panel at a pharmaceutical industry event is not easy. There is little solid ground for true dialogue, as so many companies are doing the same activity in slightly different…more...
Are patient-reported outcomes a growth industry? A business? Philadelphia's ERT apparently thinks so, having just paid $81 million for the clinical trial business of Carefusion. The purchase could increase ERT's revenue…more...
Five years ago, when Christine Pierre attempted to bring together clinical investigators and other site leaders to casually discuss their best practices, it didn't go as she'd hoped. She sent out…more...
"The industry has bottomed out and is on its way up," says Norman Goldfarb, chairman of the Model Agreement Group Initiative (MAGI), a volunteer organization dedicated to streamlining clinical research. Twice a year, on the east and west coasts respectively, Goldfarb helps to plan the MAGI conference. For 2010, the eastern conference is scheduled for the last…more...
Brad Pitt and Angelina Jolie care about drug development? They suddenly hunger to learn more about sponsor-CRO partnerships, PDUFA and Critical Path, and thus they showed up at the Drug Information Association's (DIA) 45th annual meeting to drink it all in? They are curious about science in addition to being gorgeous, rich and fertile? Wait—those were actually…more...
Hey! Can you reset my password? Now? Inside or outside the clinical trial world, that is one of the most mundane and routine requests made to software help desks. Ediary firm PHT says the ongoing hassle has now been simplified in its StudyWorks system. The system has now been updated to allow users to administer their own…more...
One surprising aspect of the clinical trial landscape is just how few PhDs and physicians share their knowledge, either as industry insiders or academic researchers. The vastness of the global research enterprise does necessarily involve large numbers of other professionals. We know that. But hearing from the experts now and then is nice. We get a large…more...
A conversation with Denis Connaghan of etrials, who recently became the new CEO of etrials.
FDA’s Sandy Kweder painted a portrait of an agency straining to deliver on the many elements of FDAAA.
The tribulations of filling your trial in the era of global studies. A report from the 2008 DIA conference.
PHT offers a new Windows device from HP for recording patient experiences.
What’s different this year. Random thoughts on our personal nemesis, paper, and the alternative.
With Mark McClellan and Janet Woodcock on the agenda, the Outcome meeting will be another illuminating event this year.
At a user meeting later this month, invivodata will unveil a new device from a company other than Palm.
Organizations
Conferences
Info & Opinion
© 2012 ClinPage. All Rights Reserved.